Publications (64) Alfonso Sánchez Ibarrola publications

2007

  1. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus- specific human CD8+ T cells

    Clinical and Experimental Immunology, Vol. 149, Núm. 1, pp. 87-96

  2. Ear, nose and throat manifestations in pemphigus vulgaris

    British Journal of Dermatology, Vol. 156, Núm. 4, pp. 733-737

2004

  1. Anti-inflammatory cytokines induce lipopolysaccharide tolerance in human monocytes without modifying toll-like receptor 4 membrane expression

    Scandinavian Journal of Immunology, Vol. 59, Núm. 6, pp. 553-558

  2. Inmunoterapia activa en el tratamiento de neoplasias hematológicas

    Anales del sistema sanitario de Navarra, Vol. 27, Núm. 1, pp. 45-62

  3. Lipopolysaccharide needs soluble CD14 to interact with TLR4 in human monocytes depleted of membrane CD14

    Microbes and Infection, Vol. 6, Núm. 11, pp. 990-995

  4. Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations [2]

    Journal of the American Academy of Dermatology, Vol. 50, Núm. 6, pp. 974-976

  5. Past, present and future of anti-idiotype vaccination

    Revista de medicina de la Universidad de Navarra, Vol. 48, Núm. 3, pp. 14-23